M. Jill Quigley's Insider Trades & SAST Disclosures
M. Jill Quigley's most recent trade in Terns Pharmaceuticals Inc was a trade of 10,657 Stock Option (Right to Buy) done . Disclosure was reported to the exchange on Feb. 1, 2025.
Add Superstar Alert
Share
Note
This is a custom search result for pattern M. Jill Quigley.To see full superstar portfolios of large investors like Warren Buffet, Elon Musk and others, click here.
Advanced/Help
"Balanced Fund": Use this format with quotation marks to find the exact phrase. The output matches
"Balanced Fund"
but not "Balanced Growth Fund"
Balanced Fund: Use this format without quotation marks to search for all funds related to the term
"Balanced Fund" The results may include
"Balanced Income Fund", "Balanced Growth Fund" and any fund name containing "Balanced Fund".
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Terns Pharmaceuticals Inc | Jill M. Quigley | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Feb 2025 | 10,657 | 10,657 | - | - | Stock Option (Right to Buy) | |
| Terns Pharmaceuticals Inc | Jill M. Quigley | Director | Sale of securities on an exchange or to another person at price $ 5.79 per share. | 02 Jan 2025 | 8,760 | 0 | - | 5.8 | 50,758 | Common Stock |
| Terns Pharmaceuticals Inc | Jill M. Quigley | Director | Sale of securities on an exchange or to another person at price $ 5.72 per share. | 02 Jan 2025 | 6,240 | 8,760 | - | 5.7 | 35,702 | Common Stock |
| Terns Pharmaceuticals Inc | Jill M. Quigley | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 09 Sep 2024 | 17,235 | 0 | - | - | Stock Option (Right to Buy) | |
| Terns Pharmaceuticals Inc | Jill M. Quigley | Director | Sale of securities on an exchange or to another person at price $ 10.00 per share. | 09 Sep 2024 | 17,235 | 15,000 | - | 10 | 172,350 | Common Stock |
| Terns Pharmaceuticals Inc | Jill M. Quigley | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 1.82 per share. | 09 Sep 2024 | 17,235 | 32,235 | - | 1.8 | 31,368 | Common Stock |
| Terns Pharmaceuticals Inc | Jill M. Quigley | Director | Sale of securities on an exchange or to another person at price $ 7.50 per share. | 01 Aug 2024 | 8,857 | 15,000 | - | 7.5 | 66,432 | Common Stock |
| Terns Pharmaceuticals Inc | Jill M. Quigley | Director | Sale of securities on an exchange or to another person at price $ 7.68 per share. | 01 Aug 2024 | 6,143 | 23,857 | - | 7.7 | 47,148 | Common Stock |
| Terns Pharmaceuticals Inc | Jill M. Quigley | Director | Sale of securities on an exchange or to another person at price $ 10.00 per share. | 15 Jul 2024 | 14,365 | 30,000 | - | 10.0 | 143,660 | Common Stock |
| Terns Pharmaceuticals Inc | Jill M. Quigley | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Jul 2024 | 14,365 | 17,635 | - | - | Stock Option (Right to Buy) | |
| Terns Pharmaceuticals Inc | Jill M. Quigley | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 1.82 per share. | 15 Jul 2024 | 14,365 | 44,365 | - | 1.8 | 26,144 | Common Stock |
| Terns Pharmaceuticals Inc | Jill M. Quigley | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Jul 2024 | 400 | 17,235 | - | - | Stock Option (Right to Buy) | |
| Terns Pharmaceuticals Inc | Jill M. Quigley | Director | Sale of securities on an exchange or to another person at price $ 10.00 per share. | 15 Jul 2024 | 400 | 30,000 | - | 10 | 4,000 | Common Stock |
| Terns Pharmaceuticals Inc | Jill M. Quigley | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 1.82 per share. | 15 Jul 2024 | 400 | 30,400 | - | 1.8 | 728 | Common Stock |
| Terns Pharmaceuticals Inc | Jill M. Quigley | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Jun 2024 | 32,000 | 32,000 | - | - | Stock Option (Right to Buy) | |
| Terns Pharmaceuticals Inc | Jill M. Quigley | Director, Sr. Advisor & Strategy Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 23 Jan 2024 | 15,000 | 30,000 | - | 0 | Common Stock | |
| Terns Pharmaceuticals Inc | Jill M. Quigley | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 16 Jun 2022 | 32,000 | 32,000 | - | - | Stock Option (Right to Buy) | |
| Passage Bio Inc | Jill Quigley M. | Chief Operating Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.23 per share. | 08 Dec 2021 | 71,975 | 368,754 (0%) | 0% | 0.2 | 16,554 | Common Stock |
| Passage Bio Inc | M. Jill Quigley | Chief Operating Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 08 Dec 2021 | 60,782 | 27,626 | - | - | Employee Stock Option (right to buy) | |
| Passage Bio Inc | M. Jill Quigley | Chief Operating Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 08 Dec 2021 | 11,193 | 3,729 | - | - | Employee Stock Option (right to buy) | |
| Terns Pharmaceuticals Inc | Jill M. Quigley | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 28 Sep 2021 | 22,000 | 22,000 | - | - | Stock Option (Right to Buy) | |
| Passage Bio Inc | Jill M. Quigley | Chief Operating Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 16 Feb 2021 | 105,000 | 105,000 | - | - | Stock Option (right to buy) | |
| Passage Bio Inc | Jill M. Quigley | Chief Operating Officer | Sale of securities on an exchange or to another person at price $ 30.01 per share. | 20 Jan 2021 | 1,300 | 295,284 (0%) | 0% | 30.0 | 39,011 | Common Stock |
| Passage Bio Inc | Jill M. Quigley | Chief Operating Officer | Sale of securities on an exchange or to another person at price $ 30.10 per share. | 14 Jan 2021 | 16,298 | 296,584 (0%) | 0% | 30.1 | 490,570 | Common Stock |
*All Values are in $ Million
Client Category: Promoter/ KMP/ Director / Immediate Relatives / Employee / etc
Security Type: Share/ Warrants / Convertible Debentures
Security Type: Share/ Warrants / Convertible Debentures
Data as reported to USA Exchanges